Recent Finacing
Recent Raise
BIMINI Biotech develops small-molecule WASp modulators for lymphomas, leukemias, and autoimmune disorders, advancing preclinical candidates and scaling a proprietary hybrid AI-driven drug discovery platform.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at BIMINI Biotech.
